420 Investor Interview with Michael Haines, CEO of Mettrum

Mettrum (TSXV:MT), which has a U.S. tracking ticker of MQTRF, is one of 30 names currently on the 420 Investor Focus List. The company, based in Toronto, holds multiple licenses to produce and sell dried cannabis and oils under the MMPR system in Canada. Mettrum Health sells its medical cannabis products using a color-coded system, Mettrum Spectrum, rather than using street names or creating branded strains. Mettrum also operates an industrial hemp division, Mettrum Originals, which sells functional foods and other products in Canada and the United States.

CEO Michael Haines was one of the founders of Mettrum. In this audio interview, which was his first since going public in 2014, he discussed his background and the backgrounds of the Mettrum executives and its Board of Directors. He described the businesses at Mettrum, including its recently launched cannabis oils, which he says are seeing strong demand initially. The overall strategy of Mettrum is to create a broad packaged goods business focused on health and wellness, though the company is preparing for the potential legalization in Canada, which would broaden the market. Haines also discussed the capital structure and the valuation of the stock.

420 Investor has extensive coverage of the Canadian MMPR licensed producers. Additionally, 420 Investor has created an index to track the market and a model portfolio with a goal to exceed the overall market as measured by that index.

Posted to Benzinga PotProfits on Apr 16, 2016 — 1:04 PM
Comments on this post have been disabled by the Maven.